GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Durect Corp (NAS:DRRX) » Definitions » Shiller PE Ratio

Durect (Durect) Shiller PE Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Durect Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Durect Shiller PE Ratio Historical Data

The historical data trend for Durect's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Durect Shiller PE Ratio Chart

Durect Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Durect Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Durect's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Durect's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Durect's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Durect's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Durect's Shiller PE Ratio falls into.



Durect Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Durect's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Durect's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.13/129.4194*129.4194
=-0.130

Current CPI (Dec. 2023) = 129.4194.

Durect Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.300 99.695 -0.389
201406 -0.500 100.560 -0.643
201409 -0.600 100.428 -0.773
201412 -0.500 99.070 -0.653
201503 -0.400 99.621 -0.520
201506 -0.500 100.684 -0.643
201509 -0.500 100.392 -0.645
201512 -0.500 99.792 -0.648
201603 -0.600 100.470 -0.773
201606 -0.700 101.688 -0.891
201609 -0.600 101.861 -0.762
201612 -0.600 101.863 -0.762
201703 -0.600 102.862 -0.755
201706 -0.700 103.349 -0.877
201709 0.400 104.136 0.497
201712 0.500 104.011 0.622
201803 -0.500 105.290 -0.615
201806 -0.400 106.317 -0.487
201809 -0.200 106.507 -0.243
201812 -0.500 105.998 -0.610
201903 -0.400 107.251 -0.483
201906 -0.400 108.070 -0.479
201909 -0.100 108.329 -0.119
201912 -0.200 108.420 -0.239
202003 -0.500 108.902 -0.594
202006 0.700 108.767 0.833
202009 -0.500 109.815 -0.589
202012 0.200 109.897 0.236
202103 -0.500 111.754 -0.579
202106 -0.400 114.631 -0.452
202109 -0.400 115.734 -0.447
202112 -0.300 117.630 -0.330
202203 -0.480 121.301 -0.512
202206 -0.510 125.017 -0.528
202209 -0.110 125.227 -0.114
202212 -0.460 125.222 -0.475
202303 -0.520 127.348 -0.528
202306 -0.460 128.729 -0.462
202309 -0.140 129.860 -0.140
202312 -0.130 129.419 -0.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Durect  (NAS:DRRX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Durect Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Durect's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Durect (Durect) Business Description

Traded in Other Exchanges
Address
10260 Bubb Road, Cupertino, CA, USA, 95014
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
Executives
Judith J. Robertson director 10260 BUBB ROAD, CUPERTINO CA 95014
Gail J Maderis director 364 LOMBARD ST., SAN FRANCISCO CA 94133
Timothy M. Papp officer: Chief Financial Officer C/O DURECT CORPORATION, 10260 BUBB ROAD, CUPERTINO CA 95014
Gail M Farfel director 142 TEMPLE STREET, SUITE 205, NEW HAVEN CT 06510
Mohammad Azab director C/O SUPERGEN, INC., 4140 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Peter S Garcia director ALX ONCOLOGY HOLDINGS INC., 866 MALCOLM ROAD, SUITE 100, BURLINGAME CA 94010
Simon X Benito director 967 LAWRENCE AVE, WESTFIELD NJ 07090
Norman Sussman officer: Chief Medical Officer C/O DURECT CORP., 10260 BUBB ROAD, CUPERTINO CA 95014
Bleichroeder Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, 47TH FLOOR, NEW YORK NY 10105
Judy R Joice officer: Sr. VP Operations & Corp QA 10260 BUBB ROAD, CUPERTINO CA 95014
21 April Fund Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, 47TH FLOOR, New York NY 10105
Jon S Saxe director FIRST HORIZON PHARMACEUTICAL CORP, 660 HEMBREE PKWY STE 106, ROSWELL GA 30076
Michael Arenberg officer: Chief Financial Officer 10260 BUBB ROAD, CUPERTINO CA 95014
James E Brown director, officer: President & CEO 10240 BUBB RD, CUPERTINO CA 95014
First Eagle Investment Management, Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105